drugset / Trial / NCT02239380
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Parallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy, safety and pharmacokinetics of Lorazepam on Japanese patients with Status Epilepticus or Repetitive Status Eplilepticus.
Timeline
- Start
- 2014-11
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorazepam | Small molecule | 0.05 mg/kg | Intravenous |
| Subject | Lorazepam | Small molecule | 4 mg | Intravenous |
Indications
No indication recorded.